Drugs / CELEXT07
last change Sep 2018 re-read 2 minutes ago

CELEXT07

Developed for
tinea unguium
Investigated by
9305-9954 Quebec Inc

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02644551 Nov 2016 → May 2018 tinea unguium 9305-9954 Quebec Inc Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CELEXT07 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02644551
Route Topical “suspension that is applied topically to the infected nail(s) daily.” NCT02644551